These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26356727)
1. The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies. Luo Y; She DL; Xiong H; Fu SJ; Yang L Medicine (Baltimore); 2015 Sep; 94(36):e1523. PubMed ID: 26356727 [TBL] [Abstract][Full Text] [Related]
2. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies. Chen Y; Li X; Zhang R; Xia Y; Shao Z; Mei Z Pharmacol Res; 2019 Mar; 141():357-365. PubMed ID: 30641276 [TBL] [Abstract][Full Text] [Related]
3. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. Park HS; Schoenfeld JD; Mailhot RB; Shive M; Hartman RI; Ogembo R; Mucci LA Ann Oncol; 2013 Jun; 24(6):1427-34. PubMed ID: 23508824 [TBL] [Abstract][Full Text] [Related]
4. The association between statin use and prognosis in esophageal cancer patients: A meta-analysis. Lv J; Chen P; Wu J; Wen Z; Zhao C Medicine (Baltimore); 2023 Mar; 102(12):e33359. PubMed ID: 36961185 [TBL] [Abstract][Full Text] [Related]
5. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis. Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of statin for cancer patients: A Meta-analysis. Li Y; Li Y; Lei X; Liu L; Zhang D; Tang S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):770-81. PubMed ID: 26267691 [TBL] [Abstract][Full Text] [Related]
7. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis. Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100 [TBL] [Abstract][Full Text] [Related]
8. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials. Xia DK; Hu ZG; Tian YF; Zeng FJ Drug Des Devel Ther; 2019; 13():405-422. PubMed ID: 30774306 [TBL] [Abstract][Full Text] [Related]
9. Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis. Xie W; Ning L; Huang Y; Liu Y; Zhang W; Hu Y; Lang J; Yang J Oncotarget; 2017 Jun; 8(25):41508-41517. PubMed ID: 28489569 [TBL] [Abstract][Full Text] [Related]
10. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis. Yao X; Liu H; Xu H Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791 [TBL] [Abstract][Full Text] [Related]
11. Impact of statin use on cancer-specific mortality and recurrence: A meta-analysis of 60 observational studies. Yang J; Li C; Shen Y; Zhou H; Shao Y; Zhu W; Chen Y Medicine (Baltimore); 2020 Apr; 99(14):e19596. PubMed ID: 32243380 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis. Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300 [TBL] [Abstract][Full Text] [Related]
14. Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis. Mass AY; Agalliu I; Laze J; Lepor H J Urol; 2012 Sep; 188(3):786-91. PubMed ID: 22818136 [TBL] [Abstract][Full Text] [Related]
15. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774 [TBL] [Abstract][Full Text] [Related]
16. The association between statin use and endometrial cancer survival outcome: A meta-analysis. Li J; Liu R; Sun Z; Tang S; Wang L; Liu C; Zhao W; Yao Y; Sun C Medicine (Baltimore); 2018 Nov; 97(47):e13264. PubMed ID: 30461633 [TBL] [Abstract][Full Text] [Related]
17. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer. Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762 [TBL] [Abstract][Full Text] [Related]
18. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862 [TBL] [Abstract][Full Text] [Related]
19. Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer. Nyame YA; Wilkins L; Greene DJ; Ganesan V; Dai C; Almassi N; Stephenson AJ; Gong M; Berglund R; Klein EA Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):617-623. PubMed ID: 30996285 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis. Luo Y; She DL; Xiong H; Fu SJ; Yang L Medicine (Baltimore); 2015 Oct; 94(40):e1670. PubMed ID: 26448011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]